Lv1
40 积分 2023-04-03 加入
Structure-Activity Relationship Study of Indolin-5-yl-cyclopropanamine Derivatives as Selective Lysine Specific Demethylase 1 (LSD1) Inhibitors
3天前
已完结
Medical Therapy for Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
7天前
已关闭
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities
8天前
已完结
Phase I study of the oral GLP ‐1 receptor agonist DA ‐ 302168S : Safety, pharmacokinetics, and pharmacodynamics in healthy and overweight/obese adults
12天前
已完结
Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of N-Acetylgalactosamine–Conjugated Small Interfering RNA Disposition and Gene Silencing in Preclinical Species and Humans
15天前
已完结
Avanafil: A comprehensive drug profile
1个月前
已完结
LC-MS/MS methods for simultaneous determination of youkenafil and its metabolite M1 in human seminal plasma and plasma: Application to evaluate the acute effect of youkenafil on semen quality and its pharmacokinetics in human
1个月前
已完结
Efficacy and safety of simenafil in men with erectile dysfunction: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group, phase 2 trial
1个月前
已完结
Attributes novel drug candidate: Constitutive GPCR signal bias mediated by purinergic receptors
2个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of HRS ‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
2个月前
已完结
皖公网安备34019202002308
